Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis - Steven D. Nathan; Peter Smith; Chunqin Deng; Christopher S. King; Maria De Salvo; S. Samuel Weigt; Sahil Pandya; Debabrata Bandyopadhyay; Joseph A. Lasky; Rachana Krishna; Nathan Hambly; Murali Ramaswamy; et al. (New England Journal of Medicine, 2026)